Gastrointestinal bleeding from Dieulafoy’s lesion: Clinical presentation, endoscopic findings, and endoscopic therapy

Table 6 Effectiveness of endoscopic ablation monotherapies for bleeding Dieulafoy’s lesions

Endoscopic procedure(No. of patients)	Lesion location	Type of study	Follow-up	Outcome	Ref.
Heater probe coagulation
EGD (6)	Stomach/duodenum	Retrospective	14 mo (2/3 of pts)	No rebleeding	[35]
EGD (6)	Stomach	Retrospective	36 mo	2 (33%) rebled	[77]
Mostly EGD (5)	Mostly stomach/duodenum	Retrospective	Hospitalization	No rebleeding	[36]
EGD (1)	Stomach	Retrospective	40 mo	No rebleeding	[72]
Argon plasma coagulation
Double balloon enteroscopy (3)	Jejunum-2, Ileum-1	Retrospective /multicenter	14 mo	1 (33%) rebled	[17]
EGD (3)	Stomach	Retrospective	2 mo	No rebleeding	[40]
EGD (1)	Likely upper GI	Retrospective	Hospitalization	No rebleeding	[36]
Multipolar electrocoagulation
EGD (14)	Stomach	Retrospective	24 mo	1 (7%) hemostasis failure, 1 rebled	[82]
EGD (1)	Likely upper GI	Retrospective	Hospitalization	Rebled	[36]